RetinaRisk
Reykjavík, Iceland
The clinically validated RetinaRisk algorithm empowers people living with diabetes and leads to more streamlined and personalized healthcare. The RetinaRisk app empowers the global diabetic population of 463 million to calculate and better understand their individualized risk of developing sight-threatening eye disease that could lead to blindness. With early detection and timely treatment vision loss can be prevented in 95% of cases. The RetinaRisk API solution serves healthcare professionals as a decision support tool to enhance the clinical safety of patients by identifying high-risk patients and can help hospitals and national healthcare systems to streamline diabetic retinopathy eye screening and make it more efficient and cost-effective.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2022
- Website
- www.retinarisk.com/
Categories
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of RetinaRisk?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now